US Patent 7399489 Exendin analog formulations

Patent 7399489 was granted and assigned to Amylin Pharmaceuticals on July, 2008 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

Amylin Pharmaceuticals

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

73994890

Patent Inventor Names

Andrew A. Young0

Orville G. Kolterman0

James J. L'Italien0

Date of Patent

July 15, 2008

Patent Application Number

112724880

Date Filed

November 10, 2005

Patent Citations Received

‌

US Patent 11884713 Acylated glucagon analogues

Patent Primary Examiner

‌

Kathleen Kerr Bragdon

Patent abstract

Novel formulations containing exendins, exendin agonists and/or exendin analogs are provided.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 7399489 Exendin analog formulations

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API